An optimal cutoff point of 77 mP is indicated (arrow). AUCROC = 0.959 (95% confidence interval = 0.908 to 0.986). FP assay can be used in the study of antigen-antibody interaction, and the attachment of fluorescein to antigen does not affect its ability to bind with an antibody. The only limitation of the FP assay is the size of the antigen, and the principle of FP assay restricts that only the micromolecular antigen is
suitable for interaction analysis. The more differences of molecular weight between antigen and antibody exist, the more differences of FP values between free antigen and antigen-antibody complex can be measured. The molecular mass of synthetic antigenic this website peptides is far smaller than general antigens, so they are suitable for the screening of antigenic epitopes by the FP method. By investigating the interaction between peptide and standard antibody sample, the antigenicity of this https://www.selleckchem.com/products/BIRB-796-(Doramapimod).html peptide can be easily determined. For instance, when the QD-labeled peptides are mixed with the Selleck PLX 4720 standard antibody in solution, if the peptides have antigenicity, they can bind with antibodies rapidly. The formations of antigen-antibody complex slow the rotation of the fluorescent tracer and thereby increase the polarization of the emitted light compared with only peptides existing in solution. On the other hand, the polarization has no change if the peptides have no antigenicity. In
other words, a high FP value SPTLC1 represents a strong antigenicity of peptides, and a low value represents a weak antigenicity of peptides after FP measure. When the peptides reacted with standard antibody-positive serum, in this report,
the measured FP values of the 10 of 11 HBV synthetic peptides were between 200 and 250 mP, far higher than the FP values of the peptides that reacted with the standard antibody-negative serum, which were only about 150 to 170 mP, and these peptides may have antigenicity. In order to optimize the FP assay used in detecting the interaction of antigenic peptide and antibody, we investigated the effects of different concentrations of fluorophore-labeled peptides, different dilution times of serum samples, and different incubation times of antigen-antibody mixture on FP assay. The obtained optimal factors are as follows: 1 nmol/L of fluorophore-labeled peptides, 1:25 of dilution times of serum samples, and 15 min of incubation time of antigen-antibody mixture. The established FP assay not only can be used to identify the antigenicity of peptides with standard antibody, but can also be used to detect antibodies in serum samples with known antigenic peptides because the usages of FP assay in the two aspects share the same principle and procedures. By analyzing the antibody levels against 10 antigenic peptides in 159 anti-HBV surface antigen-positive antiserum using FP assay, we found that the antibody levels against nos.